Related Experiment Video
Updated: Dec 17, 2025

Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice
Published on: February 3, 2016
Evaluation of Appetite-Regulating Hormones ın Young Children with Autism Spectrum Disorder
Çağla Çelikkol Sadıç1,2, Ayhan Bilgiç3, İbrahim Kılınç4
1Department of Child and Adolescent Psychiatry, Necmettin Erbakan University Meram School of Medicine, Konya, Turkey. dr.cagla90@gmail.com.
Insights
Leptin and ghrelin levels were higher in children with autism spectrum disorder (ASD). These hormones may contribute to the development of ASD, but further research is needed.
Area of Science:
- Endocrinology
- Neuroscience
- Developmental Pediatrics
Background:
- Autism spectrum disorder (ASD) is a complex neurodevelopmental condition.
- Altered appetite-regulating hormones like leptin and ghrelin have been implicated in ASD.
- The role of specific hormones, including nesfatin-1 and neuropeptide Y, in young children with ASD requires further investigation.
Purpose of the Study:
- To investigate the association between plasma levels of leptin, ghrelin, neuropeptide Y, and nesfatin-1 in young children diagnosed with autism spectrum disorder (ASD).
- To compare hormone levels between children with ASD and typically developing controls.
- To explore potential correlations between hormone levels and ASD symptom severity or eating problems.
Main Methods:
- A case-control study involving 44 children with ASD and 44 healthy controls, aged 18-60 months.
- Quantitative measurement of plasma leptin, ghrelin, neuropeptide Y, and nesfatin-1 using enzyme-linked immunosorbent assay (ELISA) kits.
- Statistical analysis to compare hormone levels between groups and assess correlations with clinical measures.
Main Results:
- Significantly elevated plasma leptin and ghrelin levels were observed in the ASD group compared to controls.
- No significant differences in plasma neuropeptide Y or nesfatin-1 levels were found between the ASD and control groups.
- No significant correlations were identified between the plasma levels of these hormones and the severity of ASD symptoms or eating problems.
Conclusions:
- Elevated leptin and ghrelin levels in young children with ASD suggest a potential role in the disorder's pathogenesis.
- Neuropeptide Y and nesfatin-1 do not appear to be significantly altered in this cohort of young children with ASD.
- Further research is warranted to elucidate the precise mechanisms by which leptin and ghrelin may influence ASD development and presentation.
Abstract:
This study aimed to investigate the role of leptin, ghrelin, neuropeptide Y, and nesfatin-1 in young children with autism spectrum disorder (ASD). A total of 44 children with ASD and 44 healthy controls aged 18-60 months were included. Plasma levels of hormones were measured using commercial enzyme-linked immunosorbent assay kits. Plasma leptin and ghrelin levels were significantly higher in the ASD group than in the control group. However, no significant difference for plasma neuropeptide Y and nesfatin-1 levels was detected between the groups. No relation was found between the severity of ASD symptoms, severity of eating problems, and plasma levels of hormones. Leptin and ghrelin may play a potential role in the pathogenesis of ASD.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Regulation of Food Intake
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Taste Buds and Receptors

